¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Organizational behavior and human performance."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • human papilloma virus test
    »ç¶÷À¯µÎÁ¾¹ÙÀÌ·¯½º°Ë»ç
  • human placental lactogen
    »ç¶÷ŹÝÁ¥»ùÀÚ±ØÈ£¸£¸ó, »ç¶÷ŹݶôÅä°Õ
  • human plasma protein fraction
    »ç¶÷Ç÷Àå´Ü¹éºÐÀ²
  • human rabies immune globulin
    »ç¶÷¹ÌÄ£°³º´¸é¿ª±Û·ÎºÒ¸°, »ç¶÷±¤°ßº´¸é¿ª±Û·ÎºÒ¸°
  • human T-cell lymphoma/leukemic virus
    »ç¶÷T¼¼Æ÷¸²ÇÁÁ¾/¹éÇ÷º´¹ÙÀÌ·¯½º
  • human T-cell lymphotropic virus
    »ç¶÷T¼¼Æ÷¸²ÇÁģȭ¹ÙÀÌ·¯½º
  • investigatory behavior
    Ž»öÇൿ
  • illness behavior
    Áúº´Çൿ
  • immune human serum globulin
    ¸é¿ª»ç¶÷Ç÷û±Û·ÎºÒ¸°
  • innate behavior
    ¼±ÃµÇൿ
  • instinctive behavior
    º»´ÉÇൿ
  • learned behavior
    ½ÀµæÇൿ, ÇнÀÇൿ
  • maladaptive behavior
    ºÎÀûÀÀÇൿ
  • motor behavior
    ¿îµ¿ÇàÀ§
  • maternal behavior
    ¸ð¼ºÇൿ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • drinking behavior
    À½ÁÖÇൿ
  • escape behavior
    µµÇÇÇൿ
  • exploratory behavior
    Ž»öÇൿ
  • health behavior
    °Ç°­ÇàÅÂ
  • illness behavior
    Áúº´Çൿ
  • innate behavior
    º»´ÉÇൿ
  • instinctive behavior
    º»´ÉÇൿ
  • investigatory behavior
    Ž»öÇൿ
  • learned behavior
    ½ÀµæÇൿ, ÇнÀÇൿ
  • maladaptive behavior
    ºÎÀûÀÀÇൿ
  • maternal behavior
    ¸ð¼ºÇൿ
  • motor behavior
    ¿îµ¿ÇàÀ§
  • problem behavior
    ¹®Á¦Çൿ
  • regressive behavior
    ÅðÇàÇൿ
  • savage behavior
    ¾ß¸¸Çൿ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • HIV => human immunodeficiency virus
    »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º
  • HIV=>human immunodeficiency virus
    ÀÎü ¸é¿ª°áÇÌ ¹ÙÀÌ·¯½º
  • HLA => human leukocyte antigen
    ÀÎüÁ¶Á÷ÀûÇÕÇ׿ø<ÀÎü¹éÇ÷±¸Ç׿ø>
  • HLA= human leukocyte antigen ; hist ocompatibility antigens ; tran splan tation antigens
    HLA<Á¶Á÷ÀûÇÕÀ̽Ä>Ç׿ø, ÀιéÇ÷±¸Ç׿ø.
  • HLA= human leukocyte antigen ; histocompatibility antigens ; transplantation anti
    HLA<Á¶Á÷ÀûÇÕÀ̽Ä>Ç׿ø, »ç¶÷¹éÇ÷±¸Ç׿ø.
  • HPV=>human papilloma virus
    ÀÎü À¯µÎÁ¾¹ÙÀÌ·¯½º
  • HTLV => human T lymphotropic virus
    »ç¶÷ T ¸²ÇÁģȭ¼º ¹éÇ÷º´
  • Human chorionic thyrotropin
    ÀÎÀ¶¸ð¸·¼ºÅ¸ÀÌ·ÎÆ®·ÎÇÉ
  • Human immunodeficiency virus = HIV
    »ç¶÷¸é¿ª°áÇ̼º ¹ÙÀÌ·¯½º
  • Human placental lactogen
    ŹÝÀ¯¼±ÀÚ±Ø(÷ÃÚïêáàÍí©Ð½)È£¸£¸ó
  • antigen, human leukocyte (HLA)
    »ç¶÷ ¹éÇ÷±¸Ç׿ø, HLAÇ׿ø
  • hCG (Human chorionic gonadotropin)
    ÀÎÀ¶¸ð¸·¼º°í³ªµµÆ®·ÎÇÉ
  • human Herpesvirus 6 (HHV-6)
    Á¦6Çü »ç¶÷ Ç츣Æä½º¹ÙÀÌ·¯½º
  • human T cell leukemia virus type I
    Á¦1Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
  • human T cell leukemia virus type I
    Á¦1Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • savage behavior
    ¾ß¸¸Àû Çൿ
  • searching behavior, of attachment loss
    Ž»öÇൿ(¾ÖÂø»ó½Ç¿¡¼­)
  • seizurelike behavior
    ¹ßÀÛÀ¯»ç Çൿ
  • sexual behavior
    ¼º(-Àû)Çൿ
  • sickroel behavior
    ȯÀÚ¿ªÇÒÇàÅÂ.
  • sociopathic behavior
    »çȸº´ÁúÀû Çൿ (¡­ú¼ÔÑ).
  • stereotyped behavior
    »óµ¿Àû Çൿ(¡­îÜ ú¼ÔÑ).
  • suicidal behavior
    ÀÚ»ìÇൿ(í»ß¯ú¼ÔÑ).
  • type A behavior
    AÇü Çൿ(ú¼ÔÑ).
  • antigen, human leukocyte (HLA)
    »ç¶÷ ¹éÇ÷±¸Ç׿ø, HLAÇ׿ø
  • citrated normal human plasma
    Á¤»óÀα¸¿¬»ê¿°Ã·°¡Ç÷Àå.
  • class I human leukocyte antigen
    Á¦ 1±Þ ÀÎü¹éÇ÷±¸Ç׿ø
  • class II human leukocyte antigen
    Á¦ 2±Þ ÀÎü¹éÇ÷±¸Ç׿ø
  • ecology, human
    Àΰ£»ýÅÂÇÐ.
  • hCG (Human chorionic gonadotropin)
    ÀÎÀ¶¸ð¸·¼º°í³ªµµÆ®·ÎÇÉ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
BEP brain evoked potential; basic element of performance
CPC central posterior curve; cerebellar Purkinje cell; cerebral palsy clinic; cerebral performance categ...
CPNE clinical performance nursing examination
CRISP Computer Retrieval of Information on Scientific Projects; Consortium Research on Indicators of Syste...
HPAC high-performance anion-exchange chromatography; hypothalamo-pituitary-adreno-cortical
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
COPM Canadian Occupational Performance Measure
CPT Continuous Performance Task
CPT Continuous Performance Test
DHPLC Denaturing High Performance Liquid Chromatography
FPLC Fast Performance Liquid Chromatography
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • atmospheric temperature and pressure
    ´ë±â Ç¥ÁØ »óÅÂ
  • atrophoderma of Pasini and Pierini
    ÆÄ½Ã´Ï ÇÇ¿¡¸®´Ï ÇǺΠÀ§ÃàÁõ
  • bone and joint surgery
    °ñ°üÀý ¿Ü°ú
  • bread and butter pericarditis
    »§-¹öÅÍ ¸ð¾ç ½É¸·¿°
  • Center for Device and Radiological Health
    ?
  • cheek and tongue retractor
    Çù¼³ °ßÀαâ
  • child abuse and neglect
    ¾Æµ¿ Çдë¿Í ¹æÄ¡
  • communication codes and characteristics
    È­ÀÇ ºÎÈ£¿Í ¼ºÁú
  • congenital and developmental bone disorder
    ¼±Ãµ¼º ¹× ¹ßÀ°¼º °ñ Àå¾Ö
  • congenital and developmental muscle disorder
    ¼±Ãµ¼º ¹× ¹ßÀ°¼º ±ÙÀå¾Ö
    Ãâ»ý ½ÃºÎÅÍ ±ÙÀúÇϸ¦ ³ªÅ¸³»°í Èå´ÃÈå´ÃÇÑ ¾ÆÀÌ. flo
  • connective tissue sheath of Key and Retzius
    Ű-·¹Ä¡¿ì½ºÀÇ °áÇÕ Á¶Á÷ ÃÊ
    ½Å°æ³»¸·, ƯÈ÷ ½Å°æ¼¶À¯ Á¾¸»Áö ÁÖÀ§ÀÇ ¾ãÀº ¿¬Àå.
  • crown and loop space maintainer
    Å©¶ó¿î¿£µå ·çÇÁÇü °£°Ý À¯Áö ÀåÄ¡
  • cultural and ethnic factor
    ¹®È­ ¹ÎÁ·Àû ¿äÀÎ
  • D and C ÀÚ±ÃÀÇ °æºÎ È®Àå°ú ³»¸· ¼ÒÆÄ.

    D factor

    D-ÀÎÀÚ
  • development of speech and language
    ÀÇ»ç ¼ÒÅëÀÇ ¹ß´Þ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
chromosomes, human, pair 2 One of the three pairs in the first group (or group a) of human chromosomes according to the current classification for humans.
(12 Dec 1998)
chromosomes, human, pair 20 One of the two pairs in the sixth group (or group f) of human chromosomes according to the current classification for humans.
(12 Dec 1998)
chromosomes, human, pair 21 One of the two pairs in the seventh group (or group g) of human chromosomes according to the current classification for humans.
(12 Dec 1998)
chromosomes, human, pair 22 One of the two pairs in the seventh group (or group g) of human chromosomes according to the current classification for humans.
(12 Dec 1998)
chromosomes, human, pair 3 One of the three pairs in the first group (or group a) of human chromosomes according to the current classification for humans.
(12 Dec 1998)
chromosomes, human, pair 4 One of the two pairs in the second group (or group b) of human chromosomes according to the current classification for humans.
(12 Dec 1998)
chromosomes, human, pair 5 One of the two pairs in the second group (or group b) of human chromosomes according to the current classification for humans.
(12 Dec 1998)
chromosomes, human, pair 6 One of the seven pairs in the third group (or group c) of human chromosomes according to the current classification for humans.
(12 Dec 1998)
chromosomes, human, pair 7 One of the seven pairs in the third group (or group c) of human chromosomes according to the current classification for humans.
(12 Dec 1998)
chromosomes, human, pair 8 One of the seven pairs in the third group (or group c) of human chromosomes according to the current classification for humans.
(12 Dec 1998)
chromosomes, human, pair 9 One of the seven pairs in the third group (or group c) of human chromosomes according to the current classification for humans.
(12 Dec 1998)
concentrated human red blood corpuscle Corpuscle prepared from one or more preparations of whole human blood which are not more than 14 days old and each of which has already been directly matched with the blood of the intended recipient.
(05 Mar 2000)
polioviruses, human 1-3 Species of enterovirus which are the causal agents of poliomyelitis in humans. Three serotypes (strains) exist: brunhilde (type 1), lansing (type 2), and leon (type 3). Transmission is by the faecal-oral route, pharyngeal secretions, or mechanical vector (flies). Both inactivated and live attenuated vaccines have proven effective in combatting the infection.
(12 Dec 1998)
coronavirus, human A species of coronavirus causing respiratory and enteric diseases in humans.
(12 Dec 1998)
hepatitis, viral, human Viral hepatitis in man.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • over and over again
    µÇÇ®ÀÌÇØ¼­
  • safe and sound
    ¹«»çÈ÷
  • touch-and-go
    ¸÷½Ã ºÒ¾ÈÇÑ
  • up-and-down
    ¿À¸£³»¸®´Â
  • Box and Cox
    µ¿½Ã¿¡´Â ¾È ³ªÅ¸³ª´Â µÎ »ç¶÷;ÇÑ ¿ªÇÒÀ» ±³´ë·Î ÇÏ´Â µÎ »ç¶÷
  • C and (&) W
    country-and-western
  • Damon and Pythias
    ´Ù¸Õ°ú ÇÇÆ¼¾Æ½º(¿¾ ±Û½º¿¡¼­ ¸ñ¼ûÀ» °É°í ¸Í¼¼¸¦ ÁöŲ µÎ Ä£±¸);µÑµµ ¾ø´Â Ä£±¸;ÀýÄ£ÇÑ Ä£±¸;¸·¿ªÇÑ ¹þ ', '
  • Daphnis and Chloe
    ´ÙÇÁ´Ï½º¿Í Ŭ·Î¿¡(2-3¼¼±â°æ ±×¸®½ºÀÇ ¸ñ°¡ÀûÀÎ À̾߱⠼ÓÀÇ ¼øÁøÇÑ ¿¬Àεé)
  • Darby and Joan
    (¹Î¿äÁßÀÇ ³ëºÎºÎ¿¡¼­);ÀÇÁÁÀº ´ÄÀº ºÎºÎ
  • Dark and Bloody Ground
    (¹Ì)KentuckyÁÖÀÇ º°¸í(ÃʱâÀÇ Àεð¾ð°úÀÇ ÀüÅõ¿Í °ü·ÃµÈ ȣĪ)
  • E.and P.
    extraordinary and plenipotentiary Ư¸í Àü±ÇÀÇ
  • Economic and Social Council
    =ECOSOC
  • Food and Agriculture Organization
    (À¯¿£) ½Ä·® ³ó¾÷ ±â±¸
  • Food and Drug Administration
    ½Äǰ ÀǾ౹(º¸°Ç ±³À° º¹Áö¼ºÀÇ ÀϺÎ)
  • Foreign and Commonwealth Office
    ¿Ü¹« ¿¬¹æ¼º
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á